Skip to main content
ELAB logo

ELAB · PMGC Holdings Inc. · Metrics

Track ELAB — free
$2.78 -0.03 (-1.07%) At close · Oct 21
Market Cap
$2.25M
Shares
809,579
Volume · Oct 21 3443 Avg daily vol (43 sessions) 49.32K

ELAB metrics

44 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.78
Market cap
$2.25M

Price action

20 metrics
Price change (1W)
-6.4%
Price change (30D)
-34.7%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
22.7
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
49,324
Relative volume
0.1
Average dollar volume
$235,417

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
809,579

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.1
reciprocal yield 743.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-599.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
31.4%
Operating margin
—
Trailing 12 months
Net margin
-1,313.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$13.49M
Trailing 12 months
Diluted EPS (TTM)
$-366,912.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$971.18

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+45,699.7%
Year over year · more shares
Revenue CAGR (3Y)
-8.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-80.6%
Return on assets
-36.9%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$18.79M
Latest balance sheet
Cash & equivalents
$18.14M
Total assets
$36.56M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$8.21M
Capital expenditures (TTM)
—
R&D (TTM)
$405,182
SG&A (TTM)
—
Stock compensation (TTM)
$206,597
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
12
13F filer change QoQ
+6
Institutional ownership
3.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
3.0%
Private-fund adviser ownership
0.5%
Active holders' share change QoQ
+178.6%
Holder tenure
1.6
Price vs estimated holder cost
-52.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.1%

Short interest

3 metrics
Short interest
3.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
34 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1840563 CUSIP 73017P607 Visit website Investor relations